大肠直肠癌筛检测试管道 - 发展阶段、细分市场、区域、监管途径、关键参与者
市场调查报告书
商品编码
1396029

大肠直肠癌筛检测试管道 - 发展阶段、细分市场、区域、监管途径、关键参与者

Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

出版日期: | 出版商: GlobalData | 英文 150 Pages | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

这份报告检查和分析了用于结直肠癌筛检测试的管道产品,并提供了全面的信息,包括不同开发阶段的产品的比较分析以及正在进行的临床试验的数据。我是。

目录

第 1 章目录

第 2 章简介

第三章开发中的产品

  • 大肠癌筛检测试 - 管道产品:依开发阶段划分
  • 大肠癌筛检测试 - 管道产品:细分市场
  • 大肠癌筛检测试 - 管道产品:按地区
  • 大肠癌筛检测试 - 管道产品:依监管途径
  • 大肠癌筛检测试 - 管道产品:依预计核准日期
  • 大肠癌筛检测试 - 正在进行的临床试验

第 4 章大肠直肠癌筛检测试 - 正在开发的在研产品:按公司划分

  • 大肠癌筛检测试公司 - 管道产品:依开发阶段划分
  • 大肠癌筛检测试 - 管道产品:依开发阶段划分

第五章大肠直肠癌筛检检测企业及产品概况

  • Acuamark Diagnostics Inc:公司概况
    • Acuamark Diagnostics Inc:管道产品和正在进行的临床试验概述
  • Anixa Diagnostics Corporation:公司概况
    • Anixa Diagnostics Corporation:管道产品和正在进行的临床试验概述
  • Arbele Corp:公司概况
    • Arbele Corp:管道产品和正在进行的临床试验概述
  • Augusta University:公司概况
    • Augusta University:管道产品和正在进行的临床试验概述
  • Bar Harbor BioTechnology Inc(不活跃):公司概况
    • Bar Harbor BioTechnology Inc(不活跃):管道产品和正在进行的临床试验概述
  • Beacon Biomedical Inc:公司概况
    • Beacon Biomedical Inc:管道产品和正在进行的临床试验概述
  • Beckman Research Institute Of The City Of Hope:公司概况
    • Beckman Research Institute Of The City Of Hope:管道产品和正在进行的临床试验概述
  • Beijing Youxun Medical Laboratory Co Ltd:公司概况
    • Beijing Youxun Medical Laboratory Co Ltd:在研产品及正在进行的临床试验概览
  • BGI Genomics Co Ltd:公司概况
    • BGI Genomics Co Ltd:管道产品和正在进行的临床试验概述
  • Biocartis Group NV:公司概况
    • Biocartis Group NV:管道产品和正在进行的临床试验概述
  • Biome Diagnostics GmbH:公司概况
    • Biome Diagnostics GmbH:管道产品和正在进行的临床试验概述
  • Castle Biosciences Inc:公司概况
    • Castle Biosciences Inc:管道产品和正在进行的临床试验概述
  • CellMax Life Inc:公司概况
    • CellMax Life Inc:管道产品和正在进行的临床试验概述
  • Celtic Medical BV:公司概况
    • Celtic Medical BV:管道产品和正在进行的临床试验概述
  • CRC Bioscreen:公司概况
    • CRC Bioscreen:管道产品和正在进行的临床试验概述
  • Creative Biosciences (Guangzhou) Co Ltd:公司概况
    • Creative Biosciences (Guangzhou) Co Ltd:在研产品及正在进行的临床试验概览
  • Curo Biosciences Pvt Ltd:公司概况
    • Curo Biosciences Pvt Ltd:管道产品和正在进行的临床试验概述
  • Diagen:公司概况
    • Diagen:管道产品和正在进行的临床试验概述
  • DiagNodus Ltd:公司概况
    • DiagNodus Ltd:管道产品和正在进行的临床试验概述
  • EHang (Suzhou) Biomedical Co Ltd:公司概况
    • EHang (Suzhou) Biomedical Co Ltd:在研产品及正在进行的临床试验概览
  • Epigenomics Inc:公司概况
    • Epigenomics Inc:管道产品和正在进行的临床试验概述
  • Exact Sciences Corp:公司概况
    • Exact Sciences Corp:管道产品和正在进行的临床试验概述
  • Foundation Medicine Inc:公司概况
    • Foundation Medicine Inc:管道产品和正在进行的临床试验概述
  • G Medical Health and Wellness:公司概况
    • G Medical Health and Wellness:管道产品和正在进行的临床试验概述
  • Geneoscopy LLC:公司概况
    • Geneoscopy LLC:管道产品和正在进行的临床试验概述
  • Genetic Technologies Ltd:公司概况
    • Genetic Technologies Ltd:管道产品和正在进行的临床试验概述
  • Genetron Health (Beijing) Co Ltd:公司概况
    • Genetron Health (Beijing) Co Ltd:在研产品及正在进行的临床试验概览
  • Genoptix Inc(不活跃):公司概述
    • Genoptix Inc(不活跃):管道产品和正在进行的临床试验概述
  • Guardant Health Inc:公司概况
    • Guardant Health Inc:管道产品和正在进行的临床试验概述
  • Human Metabolome Technologies Inc公司概况
    • Human Metabolome Technologies Inc:管道产品和正在进行的临床试验概述
  • iCellate Medical AB:公司概况
    • iCellate Medical AB:管道产品和正在进行的临床试验概述
  • Interpace Biosciences Inc:公司概况
    • Interpace Biosciences Inc:管道产品和正在进行的临床试验概述
  • JL Medi Labs Co Ltd:公司概况
    • JL Medi Labs Co Ltd:管道产品和正在进行的临床试验概述
  • Mainz Biomed NV:公司概况
    • Mainz Biomed NV:管道产品和正在进行的临床试验概述
  • mBioSys Pvt Ltd:公司概况
    • mBioSys Pvt Ltd:管道产品和正在进行的临床试验概述
  • Neuome Peptides Pte Ltd:公司概况
    • Neuome Peptides Pte Ltd:管道产品和正在进行的临床试验概述
  • Oncodiag:公司概况
    • Oncodiag:管道产品和正在进行的临床试验概述
  • Oncomark Ltd:公司概况
    • Oncomark Ltd:管道产品和正在进行的临床试验概述
  • Ourotech Ltd:公司概况
    • Ourotech Ltd:管道产品和正在进行的临床试验概述
  • Prenetics Ltd:公司概况
    • Prenetics Ltd:管道产品和正在进行的临床试验概述
  • Preora Healthcare Inc:公司概况
    • Preora Healthcare Inc:管道产品和正在进行的临床试验概述
  • QuantuMDx Group Ltd:公司概况
    • QuantuMDx Group Ltd:管道产品和正在进行的临床试验概述
  • Rarity Bioscience AB:公司概况
    • Rarity Bioscience AB:管道产品和正在进行的临床试验概述
  • Rhythm Biosciences Ltd:公司概况
    • Rhythm Biosciences Ltd:管道产品和正在进行的临床试验概述
  • Shanghai Singlera Genomics Technologies Co Ltd:公司概况
    • Shanghai Singlera Genomics Technologies Co Ltd:管道产品和正在进行的临床试验概述
  • Singlera Genomics Inc:公司概况
    • Singlera Genomics Inc:管道产品和正在进行的临床试验概述
  • The Chinese University of Hong Kong:公司概况
    • The Chinese University of Hong Kong:管道产品和正在进行的临床试验概述
  • University of Oxford:公司概况
    • University of Oxford:管道产品和正在进行的临床试验概述
  • Vastcon Inc:公司概况
    • Vastcon Inc:管道产品和正在进行的临床试验概述
  • VolitionRX Ltd:公司概况
    • VolitionRX Ltd:管道产品和正在进行的临床试验概述

第 6 章大肠直肠癌筛检测试 - 最新进展

第七章附录

Abstract

GlobalData's Medical Devices sector report, "Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Colorectal Cancer Screening Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Colorectal Cancer Screening Tests includes Guaiac Fecal Occult Blood Test (gFOBT) Kits, Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits, Fecal DNA Test Kits and Other Colorectal Cancer Screening Tests.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Colorectal Cancer Screening Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colorectal Cancer Screening Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Colorectal Cancer Screening Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Colorectal Cancer Screening Tests Overview

3 Products under Development

  • 3.1 Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
  • 3.2 Colorectal Cancer Screening Tests - Pipeline Products by Segment
  • 3.3 Colorectal Cancer Screening Tests - Pipeline Products by Territory
  • 3.4 Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
  • 3.5 Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
  • 3.6 Colorectal Cancer Screening Tests - Ongoing Clinical Trials

4 Colorectal Cancer Screening Tests - Pipeline Products under Development by Companies

  • 4.1 Colorectal Cancer Screening Tests Companies - Pipeline Products by Stage of Development
  • 4.2 Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development

5 Colorectal Cancer Screening Tests Companies and Product Overview

  • 5.1 Acuamark Diagnostics Inc Company Overview
    • 5.1.1 Acuamark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Anixa Diagnostics Corporation Company Overview
    • 5.2.1 Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Arbele Corp Company Overview
    • 5.3.1 Arbele Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Augusta University Company Overview
    • 5.4.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Bar Harbor BioTechnology Inc (Inactive) Company Overview
    • 5.5.1 Bar Harbor BioTechnology Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Beacon Biomedical Inc Company Overview
    • 5.6.1 Beacon Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Beckman Research Institute Of The City Of Hope Company Overview
    • 5.7.1 Beckman Research Institute Of The City Of Hope Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Beijing Youxun Medical Laboratory Co Ltd Company Overview
    • 5.8.1 Beijing Youxun Medical Laboratory Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 BGI Genomics Co Ltd Company Overview
    • 5.9.1 BGI Genomics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Biocartis Group NV Company Overview
    • 5.10.1 Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Biome Diagnostics GmbH Company Overview
    • 5.11.1 Biome Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Castle Biosciences Inc Company Overview
    • 5.12.1 Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 CellMax Life Inc Company Overview
    • 5.13.1 CellMax Life Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Celtic Medical BV Company Overview
    • 5.14.1 Celtic Medical BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 CRC Bioscreen Company Overview
    • 5.15.1 CRC Bioscreen Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Creative Biosciences (Guangzhou) Co Ltd Company Overview
    • 5.16.1 Creative Biosciences (Guangzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Curo Biosciences Pvt Ltd Company Overview
    • 5.17.1 Curo Biosciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Diagen Company Overview
    • 5.18.1 Diagen Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 DiagNodus Ltd Company Overview
    • 5.19.1 DiagNodus Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 EHang (Suzhou) Biomedical Co Ltd Company Overview
    • 5.20.1 EHang (Suzhou) Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Epigenomics Inc Company Overview
    • 5.21.1 Epigenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Exact Sciences Corp Company Overview
    • 5.22.1 Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Foundation Medicine Inc Company Overview
    • 5.23.1 Foundation Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 G Medical Health and Wellness Company Overview
    • 5.24.1 G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 Geneoscopy LLC Company Overview
    • 5.25.1 Geneoscopy LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 Genetic Technologies Ltd Company Overview
    • 5.26.1 Genetic Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 Genetron Health (Beijing) Co Ltd Company Overview
    • 5.27.1 Genetron Health (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 Genoptix Inc (Inactive) Company Overview
    • 5.28.1 Genoptix Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 Guardant Health Inc Company Overview
    • 5.29.1 Guardant Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 Human Metabolome Technologies Inc Company Overview
    • 5.30.1 Human Metabolome Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 iCellate Medical AB Company Overview
    • 5.31.1 iCellate Medical AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 Interpace Biosciences Inc Company Overview
    • 5.32.1 Interpace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 JL Medi Labs Co Ltd Company Overview
    • 5.33.1 JL Medi Labs Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 Mainz Biomed NV Company Overview
    • 5.34.1 Mainz Biomed NV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 mBioSys Pvt Ltd Company Overview
    • 5.35.1 mBioSys Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36 Neuome Peptides Pte Ltd Company Overview
    • 5.36.1 Neuome Peptides Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37 Oncodiag Company Overview
    • 5.37.1 Oncodiag Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38 Oncomark Ltd Company Overview
    • 5.38.1 Oncomark Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39 Ourotech Ltd Company Overview
    • 5.39.1 Ourotech Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40 Prenetics Ltd Company Overview
    • 5.40.1 Prenetics Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41 Preora Healthcare Inc Company Overview
    • 5.41.1 Preora Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42 QuantuMDx Group Ltd Company Overview
    • 5.42.1 QuantuMDx Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43 Rarity Bioscience AB Company Overview
    • 5.43.1 Rarity Bioscience AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44 Rhythm Biosciences Ltd Company Overview
    • 5.44.1 Rhythm Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45 Shanghai Singlera Genomics Technologies Co Ltd Company Overview
    • 5.45.1 Shanghai Singlera Genomics Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46 Singlera Genomics Inc Company Overview
    • 5.46.1 Singlera Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47 The Chinese University of Hong Kong Company Overview
    • 5.47.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48 University of Oxford Company Overview
    • 5.48.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49 Vastcon Inc Company Overview
    • 5.49.1 Vastcon Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50 VolitionRX Ltd Company Overview
    • 5.50.1 VolitionRX Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Colorectal Cancer Screening Tests- Recent Developments

7 Appendix

List of Tables

List of Tables

  • Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
  • Colorectal Cancer Screening Tests - Pipeline Products by Segment
  • Colorectal Cancer Screening Tests - Pipeline Products by Territory
  • Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
  • Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
  • Colorectal Cancer Screening Tests - Ongoing Clinical Trials
  • Colorectal Cancer Screening Tests Companies - Pipeline Products by Stage of Development
  • Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
  • Colorectal Cancer Screening Tests - Pipeline Products by Segment
  • Colorectal Cancer Screening Tests - Pipeline Products by Territory
  • Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
  • Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
  • Colorectal Cancer Screening Tests - Ongoing Clinical Trials